PanOptica Wraps Funding
New Jersey-based biopharmaceutical company PanOptica Inc. raised $30 million in Series A funding from SV Life Sciences and Third Rock Ventures. The company has established a board of directors that will be chaired by David Guyer, a partner of SV Life Sciences and that will include SV’s Lutz Giebel, Kevin Starr, partner of Third Rock Ventures, and Paul Chaney, CEO of PanOptica. Two additional independent board members will be appointed.
4 January 2011•5 mins read
